Literature DB >> 6581975

Induction of natural killer-like cytotoxicity in cultured human thymocytes.

M L Toribio, M O De Landázuri, M López-Botet.   

Abstract

Supernatants containing interleukin 2 (IL 2) induce strong proliferation and expression of natural killer (NK)-like activity in human thymocytes. Different supernatants were compared for: (a) IL 2 activity, (b) thymocyte proliferation capacity and (c) induction of NK-like cytotoxicity. All these activities were present in a partially purified IL2 preparation obtained by gel filtration chromatography (Mr 15 000-20 000). However, in supernatants from different sources and in the 15 000-20 000-Mr semipurified fractions, we observed that the NK-like cytotoxicity inducer effect did not correlate with either the mitogenicity or the IL2 activity. The presence in the supernatants of interleukin 1 (IL 1), interferon (IFN) or phytohemagglutinin (PHA) does not seem to be a prerequisite for the induction of NK-like cytotoxicity, since this activity was (a) fully present in supernatants devoid of IL 1, IFN and PHA, (b) absent in preparations of IL 1 and (c) not augmented after supplementation of the supernatants with IFN-gamma. We also investigated the cellular characteristics of the precursor thymocytes responsive to IL 2 supernatants. Removal of the T3+ cells at the initiation of the culture abrogated the proliferative response and eliminated the generation of NK-like cytotoxicity. Under the same conditions, removal of the HTA1+ population increased the proliferation and did not affect the NK-like activity. Our results suggest that: (a) either IL 2 is not responsible for the induction of NK-like cytotoxicity or its action is modulated by other molecules, and (b) the precursor-responder population is preferentially included in the mature T3+ subset.

Entities:  

Mesh:

Year:  1983        PMID: 6581975     DOI: 10.1002/eji.1830131203

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes.

Authors:  L L Lanier; J H Phillips
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

2.  A role for T3+4-6-8- transitional thymocytes in the differentiation of mature and functional T cells from human prothymocytes.

Authors:  M L Toribio; C Martinez; M A Marcos; C Marquez; E Cabrero; A de la Hera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Interleukin-2-induced lymphoproliferative responses.

Authors:  A Winkelstein; L D Weaver; N Salva; L L Machen
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.

Authors:  K Takahashi; Y Monden; S Saito; Y Kamamura; T Uyama
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

5.  Monocyte disorder causing cellular immunodeficiency: a family study.

Authors:  J Prieto; M L Subirá; A Castilla; M P Civeira; M Serrano
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

6.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Authors:  J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

7.  Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors.

Authors:  M L Toribio; A de la Hera; J Borst; M A Marcos; C Márquez; J M Alonso; A Bárcena; C Martínez
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

8.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Authors:  W H Chambers; N L Vujanovic; A B DeLeo; M W Olszowy; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  The heterogeneity of target recognition by lymphokine-activated killer precursor cells.

Authors:  Y Ibayashi; J D Gray; S H Golub; M Daibo; T Yamaki; T Kawahara; T Kubota; K Hashi
Journal:  Jpn J Cancer Res       Date:  1990-09

10.  Evidence that the T cell antigen receptor may not be involved in cytotoxicity mediated by gamma/delta and alpha/beta thymic cell lines.

Authors:  J H Phillips; A Weiss; B T Gemlo; A A Rayner; L L Lanier
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.